九典制药：2025年半年度归属于上市公司股东的净利润同比增长2.57%

Group 1 - The company reported a revenue of 1,511,949,503.84 yuan for the first half of 2025, representing a year-on-year growth of 10.67% [2] - The net profit attributable to shareholders of the listed company was 291,423,208.95 yuan, showing a year-on-year increase of 2.57% [2]